Sucampo Pharmaceuticals, Inc. Class A
(NASDAQ : SCMP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.52%142.380.6%$784.32m
MRKMerck & Co., Inc.
0.38%56.220.6%$704.80m
PFEPfizer Inc.
2.00%37.190.8%$585.67m
ABBVAbbVie, Inc.
1.16%97.422.1%$456.67m
LLYEli Lilly and Company
0.07%86.561.0%$305.25m
BMYBristol-Myers Squibb Company
0.42%62.391.4%$301.27m
GSKGlaxoSmithKline plc Sponsored ADR
-0.74%34.980.2%$174.16m
NVSNovartis AG Sponsored ADR
0.47%84.870.2%$106.77m
AZNAstraZeneca PLC Sponsored ADR
-0.48%33.131.3%$91.12m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.66%52.510.1%$66.72m
SNYSanofi Sponsored ADR
0.05%43.110.2%$51.33m
SCMPSucampo Pharmaceuticals, Inc. Class A
1.49%17.0014.4%$40.06m
LCILannett Company, Inc.
-1.96%27.5538.2%$22.97m
AKTXAkari Therapeutics Plc Sponsored ADR
0.97%4.172.2%$1.56m
EPIXESSA Pharma Inc
-4.55%0.210.0%$0.02m

Company Profile

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. It operates through the following geographic segments: Asia, the Americas, and Europe. It offers Lubiprostone, which treats chronic constipation, chronic idiopathic constipation in adults, irritable bowel syndrome with constipation in adult women, and opiod-induced constipation in adults with chronic non-cancer pain. The company was founded by Dr. Ryuji Ueno and Dr. Sachiko Kuno on December 5, 1996 and is headquartered in Rockville, MD.